Two related drugs with different timing
CJC-1295 vs sermorelin: what changes with IGF-1
You’ll see what these two drugs do, how their timing differs, and what no direct study has answered for you.
Where does CJC-1295 fit beside related peptides?
Sermorelin copies a short piece of a hormone your body makes [8]. It once had FDA approval to test poor growth and help some children grow, but that approval is no longer in effect. Tesamorelin is a related drug with FDA approval now for one use tied to HIV. CJC-1295 is a longer-lasting test drug with no approval for people.
A 2025 review explains how all three tell the growth gland to put out more hormone [8]. The long CJC-1295 form stays in blood far longer. That doesn’t prove it’s better or safer for you. It only explains the difference in timing.
What don’t studies tell you about these two drugs?
A fair comparison can show you how the peptides work and how long they last. It can’t tell you which one gives a better health result. Sermorelin was used in medical care before, while CJC-1295 has only early studies of IGF-1 and other blood readings [1]. No study has compared their benefits or safety head to head.
The longer stay has a downside. Growth hormone and IGF-1 may remain high for days after the long form [1]. Once a shot is given, you can’t quickly take it back. I’d place that fact beside every claim that longer must mean better. The FAQ lists the safety gaps that still face the drug and helps you frame your next IGF-1 question.
Did men keep their usual brief hormone releases?
Yes, in one small study of healthy men. Their growth hormone still came in the same number and size of brief bursts after one CJC-1295 shot [3]. Earlier work found a larger release when the gland got breaks between requests instead of one request that never stopped [6]. In other words, the men’s normal bursts didn’t become one constant flow.
Sermorelin wears off fast, so its request to the gland is brief from the start. The long form lasts longer, yet the men still had brief hormone bursts. That’s how their timing differs. The study checked hormones, not whether either drug made anyone feel better.
Which points about the two are well supported?
Both drugs make the growth gland send out growth hormone [1][8]. That hormone leads the liver to make IGF-1, the insulin-like growth factor. Long-form CJC-1295 keeps acting for days, while sermorelin acts briefly [1][2]. No direct study has ranked their benefits or safety.
Sermorelin once had approval to test poor growth and help some children grow. That approval is no longer in effect. No regulator has cleared CJC-1295 for people. If someone ranks the two for you, ask for a direct study that answers your safety question.